
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Dvl-2/Dishevelled 2/DVL2 CRISPR/Cas9 KO Plasmid (m) | sc-420081 | 20 µg | $397.00 |
Mouse Dvl2 encodes Dishevelled 2 (DVL2), a cytoplasmic scaffold protein that transduces signals from Frizzled receptors to downstream Wnt pathways. DVL2 integrates canonical Wnt/β-catenin signaling with non-canonical planar cell polarity and Wnt/Ca²⁺ cascades by coordinating receptor-proximal complexes and regulating cytoskeletal dynamics, polarity, and trafficking. Through these roles, DVL2 contributes to embryonic patterning, stem/progenitor cell behavior, and tissue homeostasis, and its dysregulation is frequently examined in contexts of aberrant Wnt signaling linked to developmental defects and oncogenic signaling programs. Dvl2 is also studied for effects on cell migration and morphogenesis, where pathway balance between β-catenin–dependent transcription and PCP outputs is critical.
Dvl-2/Dishevelled 2/DVL2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Dvl2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Dvl2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Dvl2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Dvl-2/Dishevelled 2/DVL2 protein expression.
This CRISPR knockout system enables efficient generation of Dvl2-deficient cell models for investigation of Dvl-2/Dishevelled 2/DVL2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.